Viewing Study NCT01149850


Ignite Creation Date: 2025-12-24 @ 4:49 PM
Ignite Modification Date: 2026-02-17 @ 8:57 PM
Study NCT ID: NCT01149850
Status: COMPLETED
Last Update Posted: 2024-09-19
First Post: 2010-06-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma
Sponsor: Jonsson Comprehensive Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module